Trichotillomania (Hair Pulling)

Trichotillomania is the compulsion to pull out one's hair.

Quick Answer

What it is

Trichotillomania is the compulsion to pull out one's hair.

Key findings

  • Grade D: Anxiety Symptoms (N-Acetylcysteine)
  • Grade N/A: Depression Symptoms (N-Acetylcysteine)
  • Grade N/A: Subjective Well-Being (N-Acetylcysteine)

Safety

No specific caution or interaction language was detected in the current summary/outcome notes.

ℹ️ Quick Facts

Quick Facts: Trichotillomania (Hair Pulling)

  • Supplements Studied:1
  • Research Trials:1
  • Total Participants:50
  • Top Supplement:N-Acetylcysteine (C)
1 trials
50 ppts
1 supps · 4 outcomes

Evidence-Based Protocol

Supplement stack ranked by research quality

Limited Evidence

Primary Stack (Tier 1)

1200-2400mg daily in divided doses

Glutamate modulator; best-studied supplement for trichotillomania; reduces urge to pull

5 studies | 200 participants
12-18g daily in divided doses

May help with impulse control through serotonin pathway modulation

3 studies | 80 participants

Supporting Stack (Tier 2)

2-3g EPA+DHA daily

Supports brain health and mood; may help with impulse control

4 studies | 100 participants
300-400mg daily

Supports nervous system function; may help with anxiety and stress that trigger pulling

4 studies | 100 participants
B-complex daily

Supports nervous system and mood; may help with stress management

4 studies | 100 participants
2000-4000 IU daily

Supports mood; deficiency linked to various mental health conditions

4 studies | 100 participants
5-10mg daily

Supports hair regrowth and strength once pulling stops

3 studies | 100 participants
2500-5000mcg daily

Supports hair regrowth after pulling stops

4 studies | 150 participants

How It Works

Trichotillomania (TTM) is a hair-pulling disorder where people feel compelled to pull out their hair from the scalp, eyebrows, eyelashes, or other body areas. It's classified as an obsessive-compulsive related disorder and affects about 1-2% of the population.

CHARACTERISTICS:

Recurrent, compulsive hair pulling
Tension before pulling or when resisting
Relief or pleasure when pulling
Noticeable hair loss
Distress or impairment in functioning
Not due to another medical condition

PATTERNS:

Automatic: Pulling without awareness (while reading, watching TV)
Focused: Deliberate pulling with awareness of urge
Most people have both patterns

CRITICAL: Trichotillomania is a recognized mental health condition that benefits from professional treatment. This protocol is SUPPORTIVE ONLY.

EVIDENCE-BASED TREATMENTS:

Habit Reversal Training (HRT): Most effective behavioral treatment
Cognitive Behavioral Therapy (CBT): For thoughts and emotions around pulling
Acceptance and Commitment Therapy (ACT): Building psychological flexibility
Medications: SSRIs, clomipramine, olanzapine (off-label)

ASSOCIATED CONDITIONS:

Anxiety
Depression
OCD
Skin-picking disorder
ADHD

* N-Acetyl Cysteine (NAC) has the strongest evidence for trichotillomania - shown to significantly reduce symptoms in controlled trials.

* Hair regrowth supplements (biotin, silica) can support hair regrowth once pulling is controlled.

Expected timeline: NAC may show benefit within 6-12 weeks. Behavioral therapy typically requires 10-20 sessions. Hair regrowth takes several months after pulling stops.

Generated from peer-reviewed researchSchema v2.0

Detailed Outcomes

D
Anxiety Symptoms
No effect
1 study
none
?
Depression Symptoms
1 study
Improves
?
Subjective Well-Being
1 study
Improves
?
Trichotillomania Symptoms
1 study
Improves

Research Citations (34)

Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals
PMID: 16449100
The administration of N-acetylcysteine reduces oxidative stress and regulates glutathione metabolism in the blood cells of workers exposed to lead
PMID: 23731375
N-Acetylcysteine Attenuates Fatigue Following Repeated-Bouts of Intermittent Exercise: Practical Implications for Tournament Situations
PMID: 21896942
N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study
PMID: 19581567
New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine
PMID: 16204787
Induced sputum of patients with chronic obstructive pulmonary disease (COPD) contains adhesion-promoting, therapy-sensitive factors
PMID: 10778915
N-acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial
PMID: 23131885
Systematic review and meta-analysis of the efficacy of N-acetylcysteine in the treatment of acute exacerbation of chronic obstructive pulmonary disease.
PMID: 34237968
Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial
PMID: 15866309
Long-term oral n-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD
PMID: 15607126

Related Conditions

Tobacco Use Disorder

1 shared supplement · 2 outcomes

Tobacco use disorder is a condition involving a dependence on the use of nicotine-containing tobacco products like cigarettes. It involves compulsive cravings for tobacco and cessation of use is very difficult.

Surgical Recovery

1 shared supplement · 43 outcomes

Surgical recovery refers to physiological endpoints after surgery including recovery time and adverse events including morbidity and mortality, as well as the presence of physical pain, physical comfort with everyday activities, physical independence, psychological support, and emotional well-being.

Substance Use Disorder

1 shared supplement · 2 outcomes

Substance use disorder is an abnormal mental condition characterized by an inability to control the use of legal or illegal drugs, alcohol, or medications, leading to health issues or problems at work or home.

Soccer Performance

1 shared supplement · 45 outcomes

Soccer performance refers to skills that relate to success in the sport of soccer (football) including dribbling, passing, juggling, shooting, bending, turning, goalkeeping, agility, speed, and stamina.

Schizophrenia

1 shared supplement · 69 outcomes

Schizophrenia is a brain condition that may cause auditory and/or visual hallucinations, delusions, difficulties with emotions and cognition, and verbal communication problems. These symptoms manifest between the ages of 16 and 30.

Polycystic Ovary Syndrome (PCOS)

1 shared supplement · 220 outcomes

Polycystic ovary syndrome (PCOS) is a hormone disorder that is common among women of reproductive age. PCOS is often caused by high androgen levels and frequently involves infertility, cysts on the ovaries, and metabolic abnormalities.

Overweight

1 shared supplement · 379 outcomes

Overweight is characterized as having a body mass index (BMI) of 25 to 29.9. Having overweight is associated with increased risk of conditions such as cardiovascular disease. However, this may not be the case in people with increased lean mass (e.g., athletes or weight lifters).

Obsessive-Compulsive disorder (OCD)

1 shared supplement · 8 outcomes

Obsessive compulsive disorder (OCD) is a disease characterized by intrusive and unwanted thoughts that can lead to the compulsion to perform repetitive behaviors (i.e. handwashing).